"High Efficient, Single-Use-Bioreactor simulating mammalian tissue conditions for expression and proliferation"
(HESUB)
Date du début: 1 mai 2013,
Date de fin: 30 avr. 2016
PROJET
TERMINÉ
A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for:1. continues expressing of biologicals to fulfill the expectation to “personalized medicine” and 2. proliferation of cells to support therapeutic applications and 3. proliferation of stem cells to prepare manufacturing of real “human spareparts”. Advanced process control inside tailor made and cell harboring scaffolds integrated in a High-Efficient-Single-Use-Bioreactor simulating mammalian tissue conditions will fulfill this requirements
Accédez au prémier réseau pour la cooperation européenne
Se connecter
ou
Créer un compte
Pour accéder à toutes les informations disponibles
Coordinateur
KUNGLIGA TEKNISKA HOEGSKOLAN
€ 1 291 458,00- åke Eriksson
- BRINELLVAGEN 8 100 44 STOCKHOLM (Sweden)
Details
- 75.8% € 5 752 150,00
-
FP7-HEALTH
- Projet sur CORDIS platform
4 Participants partenaires
PRESENS PRECISION SENSING GMBH
€ 922 000,00- Christian Krause
- Josef Engert Strasse 9 93053 Regensburg (Germany)
THE ELECTROSPINNING COMPANY LTD
€ 844 042,00- Robert Mckean
- WATERMARK WAY 10 SG13 7TZ HERTFORD (United Kingdom)
3H BIOMEDICAL AB
€ 898 850,00- Mallen Huang
- DAG HAMMARSKJOLDS VAG 34A 751 83 UPPSALA (Sweden)
STOBBE TECH AS
€ 1 795 800,00- Flemming Petersen
- MALMMOSEVEJ 19c 2840 HOLTE (Denmark)